Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion

NCT04499989 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

220

Enrollment

OTHER

Sponsor class

Conditions

IUCD Complication

Interventions

DRUG: INH
DRUG: Placebo Comparator

Sponsor

Aswan University Hospital